Figure 5.
Proportion of serious adverse events: (a) overall, (b) age subgroups, (c) CBD dose subgroups, (d) concomitant ASMs subgroups, and (e) epilepsy syndromes subgroups.
ASM, antiseizure medication; CBD, cannabidiol.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.